Access cutting-edge lungs; developmental disorder treatment through this phase 4 clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Cincinnati location
Preparing your pre-screening questions…
Access lungs; developmental disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lungs; developmental disorder treatment provided free
Check if you qualify for this lungs; developmental disorder clinical trial in Cincinnati, OH
No-Cost Study Care
Local to Cincinnati
Convenient for OH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Abnormalities of the lungs are common in newborns and can include aspiration or infectious pneumonia, respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), pulmonary hypertension (PH), congenital diaphragmatic hernia (CDH), and other abnormalities of lung development. Diagnostic radiography is commonly used in this population to differentiate diagnosis and to assess changes after treatment. While X-ray and CT provide quality imaging, they also expose infants to ionizing radiation. MR imaging offers a safe, non-ionizing alternative. However, imaging lungs via 1H MR is intrinsically difficult due to multiple air-tissue interfaces within the lungs causing local gradients and severe magnetic field susceptibility, which leads to an exceedingly short effective transverse relaxation time (T2\*). Additionally, the lungs have low proton density, which along with the short T2\* results in low signal to noise ratio, and the physiological motion caused by respiration and cardiac pulsation further reduces lung signal. The development of more powerful hardware, along with faster MRI techniques, has enabled detailed noninvasive 1H MR imaging of pulmonary tissues. Additionally, the development of inhaled hyperpolarized gas MRI has led to breakthroughs in the ability to visualize and quantify regional ventilation and alveolar size.
Sponsor: Children's Hospital Medical Center, Cincinnati
Yes, this clinical trial (NCT04995562) has an active research site in Cincinnati, OH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for lungs; developmental disorder treatment options in Cincinnati, OH, this clinical trial (NCT04995562) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced lungs; developmental disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all lungs; developmental disorder clinical trials near you to find additional studies recruiting in your area.
See all developmental delays clinical trials recruiting in Cincinnati — not just this study.
Browse Developmental Delays Trials in Cincinnati →